Login / Signup

Mean Platelet Volume in Crohn's Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study.

Aleksandra SobolewskaMarcin WłodarczykKrystyna Stec-MichalskaJakub FichnaMaria Wiśniewska-Jarosińska
Published in: Digestive diseases and sciences (2015)
MPV at week 14 and ΔMPV between baseline and week 14 are good predictors of sustained response to infliximab maintenance treatment in CD patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • stem cells
  • randomized controlled trial
  • patient reported
  • nk cells